z-logo
open-access-imgOpen Access
Fluoroquinolones Should Not Be the First-Line Antibiotics to Treat Community-Acquired Pneumonia in Areas of Tuberculosis Endemicity
Author(s) -
A.K. Singh
Publication year - 2007
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1086/518702
Subject(s) - medicine , pneumonia , tuberculosis , antibiotics , community acquired pneumonia , antibacterial agent , intensive care medicine , microbiology and biotechnology , pathology , biology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom